By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > Palantir: Pump The Brakes On Golden AI (NYSE:PLTR)
News

Palantir: Pump The Brakes On Golden AI (NYSE:PLTR)

News
Last updated: 2023/08/07 at 12:20 AM
By News
Share
6 Min Read
SHARE

Contents
Over HypedThe Stock Needs AI BoostTakeaway

Palantir Technologies (NYSE:PLTR) is suddenly one of the most over-hyped AI software plays around. The unliked enterprise software data play was so hated the stock traded below $8 back in early May. My investment thesis is Bearish on the stock heading in Q2’23 numbers after the close on Monday with the stock trading up to $20.

Source: Finviz

Finviz Chart

Source: Finviz

Over Hyped

Palantir guided to Q2 revenue growth of only 12% when reporting Q1 numbers with a revenue target of $530 million trailing the analyst targets of $536 million at the time. The consensus analysts are as follows:

  • Consensus EPS estimate is $0.05
  • Consensus revenue estimate is $533.57 million (12.8% YoY)

Clearly, enterprise AI software isn’t ready for prime time with this guidance. While OpenAI with Microsoft (MSFT) and Google (GOOG, GOOGL) are spending billions on generative AI programs, corporations still need to verify solutions from the likes of Palantir and implement them. Larger enterprises might have interest in AI software tools, but a company spending more money on AI isn’t necessarily a fast process.

Back on the Q1 earnings call in May, Palantir discussed a high level of interest in the new Artificial Intelligence Platform (AIP) product, but the company also discussed how working with external large language models and generative AI programs wasn’t exactly new. The key is that customer engagement isn’t the same as immediate customer demand.

On the Q1’23 earnings call back in May, Palantir highlighted how harnessing all of the AI power might be difficult for corporations:

…the accelerating pace of AI development is awe inspiring and exhilarating, but there are many challenges customers will encounter as they attempt to leverage this technology operationally at any scale. From managing the mismatch between the ever-growing big data scale of the enterprise and the bottlenecks and choke points of smaller context windows of LLM’s, to product design challenges of constructively embedding these models and workflows, and safety and trust challenges in governing the AI in an operational and decision-making context..

The news of Chat GPT-4 results degrading over time could further cause executives to pause aggressive implementation of AI software tools. The worse possible outcome is an AI chatbot providing customers with invalid results from a hallucinating chatbot.

The Stock Needs AI Boost

Palantir has already rallied back to $20 on the AI hype train. Wedbush analyst Dan Ives called the stock on the ‘golden track to success’ and slapped a $25 price target on Palantir.

After falling back to $18, the stock still trades at nearly 18x analyst sales targets. Without a massive AI boost, Palantir can’t justify the current stock valuation.

As the below chart highlights, the company has a history of slightly beating guidance. Palantir guided Q2 revenues of $530 million, though this comes after a quarter where the company did beat estimates by nearly $20 million.

Revenue Surprise chart

Source: Seeking Alpha

Remember though, without the big beat, Palantir would have again faced decelerating growth rates. The guidance for Q2 shows revenue growth hitting the lowest levels at only 12% with the company reporting a similar beat this quarter unlikely.

Even though analysts appear very bullish on the AI aspect, Palantir is only forecast to barely top a 20% growth rate in 2025. The forecast is for sales to reach just $3.2 billion in 2 years.

The stock already has a market cap of $38.5 billion and the high focus on government contracts is likely to curtail the ability to achieve accelerating growth rates. The Federal government is not an early adopter or fast to aggressively expand into new technologies.

Government revenue grew 20% in Q1 to $289 million. The company has ~55% of the revenue base from the government sector

Govt Segment slide

Source: Palantir Tech. Q1’23 presentation

A big focus in Q2 is whether the government sector works as a throttle to accelerating growth due to AI. What was originally a benefit to their advanced data platform is now a potential choke point with

Palantir needs to return to 30%+ growth to warrant higher stock prices. A stock is typically seen as expensive trading at over 10x forward sales and the AI software company needs the demand cycle to surge in order to reach the target in 2025 as follows:

  • 2023E – $2.2B
  • 2024 @ 30% – $2.86B
  • 2025 @ 30% – $3.72B

Even under this scenario, Palantir is still trading at over 10x forward sales estimates. Investors are currently expecting sales to surge far beyond a 30% growth rate while analysts are only down at 20%.

Takeaway

The key investor takeaway is that Palantir may very well be the best company positioned for enterprise AI software demand. The issue here is the time to market for new AI software options and the time customers take to implement those new software options.

The stock already factors in tons of upside potential that just isn’t guaranteed. Investors should continue looking at $20 as an opportunity to sell Palantir, not load up.

Read the full article here

News August 7, 2023 August 7, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (VLRS) M&A Call Transcript

By News
News

Altimmune, Inc. (ALT) Discusses Topline 48-Week Results From IMPACT Phase IIb Trial of Pemvidutide in MASH Transcript

By News
News

Italian Confidence Ticks Up, Led By An Olympics-Driven Tourism Boost

By News
News

2026 Market Outlook: The Year Of Real Assets As AI Hype Reaches Peak

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?